Thus far, the molecular mechanisms of the conformational conversion of PrPC into infectious prions and other key neurodegenerative processes in prion diseases remain unclear, which is a road block for developing effective therapeutic strategies against these devastating neurodegenerative disorders[8]. Here, PRNP is linked to prion disease.